Welcome to LookChem.com Sign In|Join Free

CAS

  • or

78561-22-5

Post Buying Request

78561-22-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78561-22-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 78561-22-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,5,6 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 78561-22:
(7*7)+(6*8)+(5*5)+(4*6)+(3*1)+(2*2)+(1*2)=155
155 % 10 = 5
So 78561-22-5 is a valid CAS Registry Number.

78561-22-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-O-TRITYL-1,2,3,4-TETRA-O-BENZYL-A-D-MANNOPYRANOSE

1.2 Other means of identification

Product number -
Other names 1,2,3,4-Tetra-O-benzyl-6-O-trityl-a-D-mannopyranose

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78561-22-5 SDS

78561-22-5Relevant articles and documents

Pharmaceutical composition for inhibiting tumor cell growth and application thereof

-

, (2019/06/05)

The invention discloses a pharmaceutical composition for inhibiting tumor cell growth. Its effective components include M6CP-OEt, the structural formula of M6CP-OEt is shown in the description. M6CP-OEt in the pharmaceutical composition can inhibit the gr

A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity

Doores, Katie J.,Fulton, Zara,Hong, Vu,Patel, Mitul K.,Scanlan, Christopher N.,Wormald, Mark R.,Finn,Burton, Dennis R.,Wilson, Ian A.,Davis, Benjamin G.

scheme or table, p. 17107 - 17112 (2011/02/25)

Antibody 2G12 uniquely neutralizes a broad range of HIV-1 isolates by binding the high-mannose glycans on the HIV-1 surface glycoprotein, gp120. Antigens that resemble these natural epitopes of 2G12 would be highly desirable components for an HIV-1 vaccine. However, host-produced (self)-carbohydrate motifs have been unsuccessful so far at eliciting 2G12-like antibodies that cross-react with gp120. Based on the surprising observation that 2G12 binds nonproteinaceous monosaccharide D-fructose with higher affinity than D-mannose, we show here that a designed set of nonself, synthetic monosaccharides are potent antigens. When introduced to the terminus of the D1 arm of protein glycans recognized by 2G12, their antigenicity is significantly enhanced. Logical variation of these unnatural sugars pinpointed key modifications, and the molecular basis of this increased antigenicity was elucidated using high-resolution crystallographic analyses. Virus-like particle protein conjugates containing such nonself glycans are bound more tightly by 2G12. As immunogens they elicit higher titers of antibodies than those immunogenic conjugates containing the self D1 glycan motif. These antibodies generated from nonself immunogens also cross-react with this self motif, which is found in the glycan shield, when it is presented in a range of different conjugates and glycans. However, these antibodies did not bind this glycan motif when present on gp120.

Synthesis of O-β-D-galactopyranosyl-(14)-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(16)-D-mannopyranose

Arnarp, Jan,Loenngren, Joergen,Ottoson, Hakan

, p. 154 - 156 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78561-22-5